Report ID: SQMIG35I2509
Report ID:
SQMIG35I2509 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
121
|Figures:
77
Global Vitamins Market size was valued at USD 5.8 Billion in 2024 and is poised to grow from USD 6.17 Billion in 2025 to USD 10.05 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).
KONINKLIJKE DSM N.V., GLANBIA PLC, ADM, BASF SE, LONZA GROUP, Kemin Industries Inc., Evonik Industries AG, Givaudan S.A., Bayer AG, DSM-Firmenich AG, Nutraceuticals Group, Maypro Industries Inc., Prinova Group LLC, Zhejiang NHU co., Ltd., Rabar Pty Ltd., Farbest-Tallman Foods Corporation, Newgen Pharma, The Merck Group, Zhejiang Medicine co., Ltd., RABAR PTY LTD.
The key driver of the Vitamins Market is the rising consumer focus on preventive healthcare and wellness. Increasing health awareness, growing demand for dietary supplements, aging populations, and the shift toward immunity-boosting products are significantly fueling global market growth.
Key trends in the Vitamins Market include rising demand for immunity-boosting supplements, growth of plant-based and clean-label vitamins, increasing popularity of personalized nutrition, expansion of online retail channels, and innovation in gummy, chewable, and functional vitamin formulations targeting specific health needs.
North America accounted for the largest share in the Vitamins Market, driven by high consumer awareness of dietary supplements, strong preventive healthcare culture, widespread availability of vitamin products, and increasing demand for immunity and wellness-focused formulations across the region.
Feedback From Our Clients
Report ID: SQMIG35I2509